(Q60636813)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author

José M Gallego-Escuredo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Javier Gómez-Ambrosi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Victoria Catalan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Marta Giralt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Francesc Villarroya

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

P Domingo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

G Frühbeck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

12 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

121-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2014.76

18 March 2020

exact match

0 references

cites work

TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway

1 reference

12 December 2020

Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians

1 reference

12 December 2020

Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction

1 reference

12 December 2020

FGF21 reloaded: challenges of a rapidly growing field

1 reference

12 December 2020

Increased responses to the actions of fibroblast growth factor 21 on energy balance and body weight in a seasonal model of adiposity

1 reference

12 December 2020

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity.

1 reference

12 December 2020

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

1 reference

12 December 2020

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

1 reference

12 December 2020

Changes of plasma fibroblast growth factor-21 (FGF-21) in oral glucose tolerance test and effects of metformin on FGF-21 levels in type 2 diabetes mellitus

1 reference

12 December 2020

Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis

1 reference

12 December 2020

Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently

1 reference

12 December 2020

Carbohydrate feeding dissociates the postprandial FGF19 response from circulating bile acid levels in humans

1 reference

12 December 2020

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

1 reference

12 December 2020

Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity

1 reference

12 December 2020

A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass

1 reference

12 December 2020

βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism

1 reference

12 December 2020

Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis

1 reference

12 December 2020

The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes

1 reference

12 December 2020

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

1 reference

12 December 2020

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

1 reference

12 December 2020

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

1 reference

12 December 2020

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

1 reference

12 December 2020

Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance

1 reference

12 December 2020

Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis

1 reference

12 December 2020

Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass.

1 reference

12 December 2020

BetaKlotho is required for metabolic activity of fibroblast growth factor 21

1 reference

12 December 2020

Air displacement plethysmography: validation in overweight and obese subjects.

1 reference

12 December 2020

The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue

1 reference

12 December 2020

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

1 reference

12 December 2020

1 reference

12 December 2020

Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue

1 reference

12 December 2020

Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho

1 reference

12 December 2020

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

1 reference

12 December 2020

Follow-up report on the diagnosis of diabetes mellitus

1 reference

12 December 2020

Fibroblast growth factor 21 corrects obesity in mice

1 reference

12 December 2020

Mini-review: endocrine actions of fibroblast growth factor 19.

1 reference

12 December 2020

Depot-Specific Expression of Fibroblast Growth Factors in Human Adipose Tissue

1 reference

12 December 2020

Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.

1 reference

12 December 2020

Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR.

1 reference

12 December 2020

Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.

1 reference

12 December 2020

Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice

1 reference

12 December 2020

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

1 reference

12 December 2020

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

1 reference

12 December 2020

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity

1 reference

12 December 2020

Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

1 reference

12 December 2020

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

1 reference

12 December 2020

FGF-21 as a novel metabolic regulator

1 reference

12 December 2020

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

1 reference

12 December 2020

Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients

1 reference

12 December 2020

Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass.

1 reference

12 December 2020

Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-α agonist treatment.

1 reference

12 December 2020

High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects

1 reference

12 December 2020

Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).

1 reference

12 December 2020

Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin

1 reference

12 December 2020

Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo

1 reference

12 December 2020

Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats

1 reference

12 December 2020

Lowering the criterion for impaired fasting glucose is in order

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FIJO.2014.76

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/IJO.2014.76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24813368%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference